Nerve-heat treatment plus allergy shots for dust mite congestion
Part of Ear, nose & throat, Immune system & allergy clinical trials.
This study tests whether heating tissue in the nose (radiofrequency ablation) followed by allergy treatment under the skin (immunotherapy) can reduce long-lasting nasal congestion from dust mite allergy. It may help patients whose symptoms are severe and who have not been able to get enough relief with recent allergy medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 60 years old.
- You’ve had dust mite allergy rhinitis for at least 2 years confirmed by skin prick or blood allergy test.
- Your main problem is severe nasal congestion (score 7 or higher) with enlarged lower nose tissue (inferior turbinates).
- You have not used oral steroid pills for 4 weeks before starting.
- You have not used allergy nasal sprays or antihistamine medications for 2 weeks before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
This study observes how well patients tolerate a specific updosing plan for a house dust mite allergy treatment (Novo-Helisen Depot). It includes children, teens, and adults who are already getting the treatment as part of normal care.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests a new way of giving allergy shots directly into the tonsils to treat dust mite allergies that cause runny nose, sneezing, and itchy eyes. It aims to see if this method is safer and works better than standard treatment.
Hear when a new Allergic Rhinitis Due to House Dust Mite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.